MXPA03004463A - Composiciones medicas. - Google Patents

Composiciones medicas.

Info

Publication number
MXPA03004463A
MXPA03004463A MXPA03004463A MXPA03004463A MXPA03004463A MX PA03004463 A MXPA03004463 A MX PA03004463A MX PA03004463 A MXPA03004463 A MX PA03004463A MX PA03004463 A MXPA03004463 A MX PA03004463A MX PA03004463 A MXPA03004463 A MX PA03004463A
Authority
MX
Mexico
Prior art keywords
pharmacologically acceptable
pharmaceutical composition
esters
acceptable salts
medicinal compositions
Prior art date
Application number
MXPA03004463A
Other languages
English (en)
Inventor
Toshio Sada
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26604360&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA03004463(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of MXPA03004463A publication Critical patent/MXPA03004463A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
MXPA03004463A 2000-11-21 2001-11-19 Composiciones medicas. MXPA03004463A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000354327 2000-11-21
JP2001164009 2001-05-31
PCT/JP2001/010095 WO2002041890A1 (fr) 2000-11-21 2001-11-19 Compositions medicinales

Publications (1)

Publication Number Publication Date
MXPA03004463A true MXPA03004463A (es) 2003-08-19

Family

ID=26604360

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03004463A MXPA03004463A (es) 2000-11-21 2001-11-19 Composiciones medicas.

Country Status (24)

Country Link
US (2) US6878703B2 (es)
EP (2) EP1336407B1 (es)
KR (1) KR100656716B1 (es)
CN (1) CN1265788C (es)
AT (1) ATE324890T1 (es)
AU (2) AU2002214324B2 (es)
BR (1) BR0115516A (es)
CA (1) CA2429260A1 (es)
CY (1) CY1106134T1 (es)
CZ (1) CZ20031367A3 (es)
DE (1) DE60119368T2 (es)
DK (1) DK1336407T3 (es)
ES (1) ES2262689T3 (es)
HK (1) HK1054692A1 (es)
HU (1) HUP0400553A3 (es)
IL (2) IL155965A0 (es)
MX (1) MXPA03004463A (es)
NO (1) NO332938B1 (es)
NZ (1) NZ525913A (es)
PL (1) PL207252B1 (es)
PT (1) PT1336407E (es)
SK (1) SK5992003A3 (es)
TW (1) TWI262076B (es)
WO (1) WO2002041890A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3045174A1 (en) * 2003-01-31 2016-07-20 Daiichi Sankyo Company, Limited Medicine for prevention of and treatment for arteriosclerosis and hypertension
US20040198789A1 (en) * 2003-02-28 2004-10-07 Recordati Ireland Limited Lercanidipine/ARB/diuretic therapeutic combinations
CA2536975A1 (en) 2003-08-28 2005-03-17 Nitromed, Inc. Nitrosated and nitrosylated diuretic compounds, compositions and methods of use
KR20090102883A (ko) * 2004-09-02 2009-09-30 테바 파마슈티컬 인더스트리즈 리미티드 올메살탄 메독소밀의 정제
US20070054948A1 (en) * 2004-09-02 2007-03-08 Lilach Hedvati Purification of olmesartan medoxomil
CN1993355A (zh) * 2004-09-02 2007-07-04 特瓦制药工业有限公司 奥美沙坦酯的纯化方法
JP2008531579A (ja) 2005-02-24 2008-08-14 ニトロメッド インコーポレーティッド 酸化窒素増強利尿化合物、組成物および使用方法
WO2006123765A1 (ja) * 2005-05-20 2006-11-23 Daiichi Sankyo Company, Limited フィルムコーティング製剤
CN101180052B (zh) * 2005-05-20 2010-11-17 第一三共株式会社 含有右旋糖的薄膜包衣制剂
WO2007047838A2 (en) * 2005-10-20 2007-04-26 Dr. Reddy's Laboratories Ltd. Process for preparing olmesartan medoxomil
US8077769B2 (en) * 2006-03-28 2011-12-13 Sony Corporation Method of reducing computations in transform and scaling processes in a digital video encoder using a threshold-based approach
EP1891952B1 (en) * 2006-05-04 2011-10-05 LEK Pharmaceuticals d.d. Pharmaceutical composition of olmesartan medoxomil
JP2010508266A (ja) * 2006-10-30 2010-03-18 ハナル ファーマシューティカル カンパニー リミテッド チアジド系化合物およびアンジオテンシン−ｉｉ−受容体遮断剤を含む放出性が制御された薬学的組成物
JP5554699B2 (ja) 2008-03-13 2014-07-23 第一三共株式会社 オルメサルタンメドキソミルを含む製剤の溶出性の改善
US20100008956A1 (en) * 2008-07-08 2010-01-14 Jie Du Composition and combinations of carboxylic acid losartan in dosage forms
DE102008059206A1 (de) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
WO2010075347A2 (en) 2008-12-23 2010-07-01 Takeda Pharmaceutical Company Limited Methods of treating hypertension with at least one angiotensin ii receptor blocker and chlorthalidone
IT1400311B1 (it) 2010-05-10 2013-05-24 Menarini Int Operations Lu Sa Associazione di inibitori della xantina ossidasi e antagonisti del recettore dell'angiotensina ii e loro uso.
EP3807898A1 (en) 2018-06-14 2021-04-21 AstraZeneca UK Limited Methods for treatment of hypertension with an angiotensin ii receptor blocker pharmaceutical composition

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2976289A (en) 1961-03-21 X-tetrahydro -
US3009911A (en) 1961-11-21 Derivatives of j
US3108097A (en) * 1963-10-22 Ehnojs
US3025292A (en) * 1962-03-13 Reduction of i
US2783241A (en) 1957-02-26 S-acylimino-x-substituted-az-i
US3254076A (en) 1966-05-31 Sulfamyl hydro
US2554816A (en) 1950-04-04 1951-05-29 American Cyanamid Co Heterocyclic sulfonamides and methods of preparation thereof
GB795174A (en) 1954-10-13 1958-05-21 Upjohn Co Heterocyclic sulphonamides
US2835702A (en) 1956-05-02 1958-05-20 Merck & Co Inc Benzene 1, 3 disulfonamides possessing diuretic properties
US2980679A (en) 1957-04-04 1961-04-18 Omikron Gagliardi Societa Di F Process for preparing heterocyclic sulfonamides
US3055904A (en) 1957-11-04 1962-09-25 Geigy Chem Corp New isoindoline derivatives
GB851287A (en) 1958-07-10 1960-10-12 British Drug Houses Ltd 5-chlorotoluene-2:4-disulphonamide and alkali metal salts thereof
US3058882A (en) * 1959-12-28 1962-10-16 Hoechst Ag N'-substituted-3-carboxy-6-halo-sulfanilamide and derivatives thereof
US3255241A (en) 1961-01-19 1966-06-07 Merck & Co Inc (2-alkylidene acyl)phenoxy-and (2-alkylidene acyl)phenylmercaptocarboxylic acids
GB979994A (en) * 1961-07-28 1965-01-06 May & Baker Ltd Isoindolinone derivatives
US3265573A (en) 1962-07-27 1966-08-09 Squibb & Sons Inc Benzothiadiazinesulfonamide-1, 1-dioxide composition
NL299931A (es) 1962-10-30
DE1278443C2 (de) 1963-11-30 1975-07-24 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 2,4-disulfonamid-1-chlorbenzolen
US3163645A (en) 1964-09-25 1964-12-29 Ciba Geigy Corp Derivatives of 3, 4-dihydro-2-h-[1, 2, 4]-benzothiadiazine-1, 1-dioxides
DE1270544B (de) * 1965-06-19 1968-06-20 Beiersdorf Ag 4-Chlor-5-sulfamylsalicylsaeure-(2', 6'-dimethyl)-anilid und dessen Alkali- oder Ammonium-Salze sowie Verfahren zu deren Herstellung
US3360518A (en) * 1966-01-03 1967-12-26 Wallace & Tiernan Inc Tetrahydro-halo-sulfamyl quinazolinones
US3634583A (en) * 1969-07-24 1972-01-11 Leo Pharm Prod Ltd Pharmaceutical composition for the treatment of oedematous conditions and hypertension
BE757001A (fr) 1969-10-10 1971-03-16 Cerpha Derives heterocycliques d'acides phenoxy acetique et leur preparation
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
EP0733366B1 (en) * 1988-01-07 1998-04-01 E.I. Du Pont De Nemours And Company Pharmaceutical compositions comprising angiotensin II receptor blocking imidazoles and diuretics
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
EP0400835A1 (en) * 1989-05-15 1990-12-05 Merck & Co. Inc. Substituted benzimidazoles as angiotensin II antagonists
US5656650A (en) * 1990-12-14 1997-08-12 Smithkline Beecham Corp. Angiotensin II receptor blocking compositions
FI112942B3 (fi) * 1991-02-21 2012-03-13 Daiichi Sankyo Co Ltd Menetelmä kohonneen verenpaineen hoitoon ja ennaltaehkäisyyn käyttökelpoisten 4'-(1H-imidatsol-1-yylimetyyli)-1,1' -bifenyylijohdannaisten valmistamiseksi
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
US5310928A (en) * 1991-11-18 1994-05-10 E. I. Du Pont De Nemours And Company Process for preparing biphenyltetrazole compounds
US5264447A (en) * 1992-09-01 1993-11-23 Merck & Co., Inc. Angiotensin II antagonist

Also Published As

Publication number Publication date
US20050113367A1 (en) 2005-05-26
ES2262689T3 (es) 2006-12-01
HUP0400553A3 (en) 2010-03-29
CN1486182A (zh) 2004-03-31
DE60119368D1 (de) 2006-06-08
BR0115516A (pt) 2004-02-03
CN1265788C (zh) 2006-07-26
PL207252B1 (pl) 2010-11-30
EP1595540A1 (en) 2005-11-16
PL361093A1 (en) 2004-09-20
US6878703B2 (en) 2005-04-12
ATE324890T1 (de) 2006-06-15
EP1336407A1 (en) 2003-08-20
SK5992003A3 (en) 2003-11-04
CZ20031367A3 (cs) 2003-10-15
EP1336407A4 (en) 2004-07-14
DE60119368T2 (de) 2007-05-03
IL155965A0 (en) 2003-12-23
AU1432402A (en) 2002-06-03
NO332938B1 (no) 2013-02-04
NO20032261L (no) 2003-07-09
HK1054692A1 (en) 2003-12-12
EP1336407B1 (en) 2006-05-03
WO2002041890A1 (fr) 2002-05-30
CY1106134T1 (el) 2011-06-08
US20040002529A1 (en) 2004-01-01
CA2429260A1 (en) 2002-05-30
DK1336407T3 (da) 2006-09-04
PT1336407E (pt) 2006-07-31
KR100656716B1 (ko) 2006-12-13
NO20032261D0 (no) 2003-05-20
KR20030096235A (ko) 2003-12-24
TWI262076B (en) 2006-09-21
AU2002214324B2 (en) 2004-07-29
NZ525913A (en) 2004-05-28
IL155965A (en) 2008-08-07
HUP0400553A2 (hu) 2004-06-28

Similar Documents

Publication Publication Date Title
AU1432402A (en) Medicinal compositions
MY141661A (en) 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
MXPA04004674A (es) Ligados de los receptors de los canabinodies.
MXPA02011974A (es) Derivados de quinazolina sustituidos y su uso como inhibidores.
YU68102A (sh) Derivati karboksilne kiseline kao ip antagonisti
ATE377602T1 (de) Morphinanderivate und ihre medizinische anwendung
SE9904508D0 (sv) New compounds
MXPA05008142A (es) Medicamento para la profilaxis y el tratamiento de arteriosclerosis e hipertension.
WO2003049690A3 (en) Hiv integrase inhibitors
AU2003223340A8 (en) Certain pharmaceutically useful substituted aminoalkyl heterocycles
HU9801950D0 (en) 2-(arylphenyl)-amino-imidazoline derivatives
WO2002026732A1 (fr) Derive de benzodiazepine
IL122753A (en) (R)-5-bromo-N-(1-ethyl-4-methylhexahydro-1H-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridinecarboxamide its preparation and pharmaceutical compositions containing same
NO983444L (no) Benzo(c)kinolizin derivater, deres fremstilling og anvendelse som 5<alfa>-reduktaseinhibitorer
AU7109798A (en) Substituted thiazolidinedione and oxazolidinedione having antidiabetic, hypol ipidemia and antihypertensive properties
ATE301997T1 (de) Antivirale therapie
DE60104288D1 (de) Antivirale therapie
EP1210948A4 (en) DRUGS FOR NERVOUS DISEASES

Legal Events

Date Code Title Description
FG Grant or registration
GB Transfer or rights